相关实验视频

Updated: May 17, 2025

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Oral Administration of Rotenone using a Gavage and Image Analysis of Alpha-synuclein Inclusions in the Enteric Nervous System

Published on: October 26, 2010

使用sim (Rhodomyrtus tomentosa) 果水提取物准帕金森病

Ngo Binh Thao Nghi^1,2, Dao My Linh^1,2, Dang Thi Phuong Thao^3,4,5

¹Department of Molecular and Environmental Biotechnology, Faculty of Biology and Biotechnology, University of Science, 227 Nguyen Van Cu St, Dist 5, Ho Chi Minh City, Vietnam.

BMC complementary medicine and therapies

|May 14, 2025

概括

在Drosophila模型中,Sim水果提取物通过减少氧化应激和改善运动功能来显示帕金森病 (PD) 治疗的潜力. 这种天然化合物为PD提供了一个有希望的,安全的治疗候选物.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
生物化学生物化学

背景情况:

帕金森病 (PD) 是一种神经退行性疾病,其特征是多巴胺基神经元损失,导致运动缺陷和生活质量下降.
目前的PD疗法提供症状缓解,但缺乏疾病修饰作用;需要针对氧化应激等潜在机制的新型治疗方法.
具有抗氧化特性的天然化合物正在被探索为PD的潜在治疗剂,为长期使用合成药物提供更安全的替代品.

研究的目的:

调查Sim果水提取物 (SFWE) 对帕金森病 (PD) 的治疗潜力.
在PD Drosophila模型中评估SFWE的抗氧化能力及其对多巴氨基神经元退化和运动器官功能障碍的影响.

主要方法:

利用Drosophila melanogaster模型与dUCH的淘汰来模仿PD症状,包括多巴胺基神经元退化和运动障碍.
通过IC50值的确定来评估SFWE的抗氧化能力.
给PD模型施用SFWE,以评估其对活性氧物种 (ROS) 水平,多巴胺基神经元存活率和运动功能的影响.

主要成果:

SFWE表现出显著的抗氧化能力,其IC50值为55.55 ± 2.012 μg/mL.
SFWE治疗 (1.25 mg/mL) 有效地降低了PD模型中多巴胺基神经元中的ROS水平.
在PD Drosophila模型中,SFWE改善了多巴胺能神经元退化,并挽救了运动器官缺陷.
SFWE没有对果的发育或寿命产生不利影响,这表明它具有良好的安全性.

结论:

辛果水提取物具有强大的抗氧化特性,并显示出对抗氧化应激诱导的神经退行症的神经保护作用.
在相关的动物模型中,SFWE有效地减轻了帕金森病的标志性症状,包括多巴胺基神经元损失和运动功能障碍.
辛果是一种有前途的天然来源,可用于开发新,安全和有效的帕金森病治疗策略.

关键词:

德意志的敲击击下来了.这种植物是Drosophila melanogaster.氧化应激是一种氧化应激.帕金森病是帕金森病的一种.西姆果水提取物果水提取物

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...